These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30886417)

  • 1. Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin.
    Ye L; Schnepf D; Becker J; Ebert K; Tanriver Y; Bernasconi V; Gad HH; Hartmann R; Lycke N; Staeheli P
    Nat Immunol; 2019 May; 20(5):593-601. PubMed ID: 30886417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines.
    Ye L; Ohnemus A; Ong LC; Gad HH; Hartmann R; Lycke N; Staeheli P
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-λ Improves the Efficacy of Intranasally or Rectally Administered Influenza Subunit Vaccines by a Thymic Stromal Lymphopoietin-Dependent Mechanism.
    Ye L; Schnepf D; Ohnemus A; Ong LC; Gad HH; Hartmann R; Lycke N; Staeheli P
    Front Immunol; 2021; 12():749325. PubMed ID: 34659250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
    Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
    J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-λ modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus.
    Hemann EA; Green R; Turnbull JB; Langlois RA; Savan R; Gale M
    Nat Immunol; 2019 Aug; 20(8):1035-1045. PubMed ID: 31235953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.
    Nguyen HH; van Ginkel FW; Vu HL; Novak MJ; McGhee JR; Mestecky J
    J Virol; 2000 Jun; 74(12):5495-501. PubMed ID: 10823854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct and nonredundant role for thymic stromal lymphopoietin on antiviral CD8 T cell responses in the respiratory mucosa.
    Shane HL; Klonowski KD
    J Immunol; 2014 Mar; 192(5):2261-70. PubMed ID: 24489089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.
    Lee YT; Ko EJ; Lee Y; Lee YN; Bian Z; Liu Y; Kang SM
    J Virol; 2016 Aug; 90(15):6746-6758. PubMed ID: 27194758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III interferon exerts thymic stromal lymphopoietin in mediating adaptive antiviral immune response.
    Cao L; Qian W; Li W; Ma Z; Xie S
    Front Immunol; 2023; 14():1250541. PubMed ID: 37809098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses.
    Mordstein M; Kochs G; Dumoutier L; Renauld JC; Paludan SR; Klucher K; Staeheli P
    PLoS Pathog; 2008 Sep; 4(9):e1000151. PubMed ID: 18787692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.
    Ji X; Ren Z; Xu N; Meng L; Yu Z; Feng N; Sang X; Li S; Li Y; Wang T; Zhao Y; Wang H; Zheng X; Jin H; Li N; Yang S; Cao J; Liu W; Gao Y; Xia X
    Viruses; 2016 Apr; 8(4):115. PubMed ID: 27110810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of Type III Interferon (IFN) Genes
    Peterson ST; Kennedy EA; Brigleb PH; Taylor GM; Urbanek K; Bricker TL; Lee S; Shin H; Dermody TS; Boon ACM; Baldridge MT
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice.
    Price GE; Gaszewska-Mastarlarz A; Moskophidis D
    J Virol; 2000 May; 74(9):3996-4003. PubMed ID: 10756011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses.
    Torrieri-Dramard L; Lambrecht B; Ferreira HL; Van den Berg T; Klatzmann D; Bellier B
    Mol Ther; 2011 Mar; 19(3):602-11. PubMed ID: 20959813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection.
    Wang BZ; Xu R; Quan FS; Kang SM; Wang L; Compans RW
    PLoS One; 2010 Nov; 5(11):e13972. PubMed ID: 21124769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide oligomerization and binding domain 2-dependent dendritic cell activation is necessary for innate immunity and optimal CD8+ T Cell responses to influenza A virus infection.
    Lupfer C; Thomas PG; Kanneganti TD
    J Virol; 2014 Aug; 88(16):8946-55. PubMed ID: 24872587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSLP promotes influenza-specific CD8+ T-cell responses by augmenting local inflammatory dendritic cell function.
    Yadava K; Sichelstiel A; Luescher IF; Nicod LP; Harris NL; Marsland BJ
    Mucosal Immunol; 2013 Jan; 6(1):83-92. PubMed ID: 22806096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus.
    Rajesh Kumar S; Syed Khader SM; Kiener TK; Szyporta M; Kwang J
    PLoS One; 2013; 8(6):e63856. PubMed ID: 23762234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.
    Kayamuro H; Yoshioka Y; Abe Y; Arita S; Katayama K; Nomura T; Yoshikawa T; Kubota-Koketsu R; Ikuta K; Okamoto S; Mori Y; Kunisawa J; Kiyono H; Itoh N; Nagano K; Kamada H; Tsutsumi Y; Tsunoda S
    J Virol; 2010 Dec; 84(24):12703-12. PubMed ID: 20881038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice.
    Tan AC; Mifsud EJ; Zeng W; Edenborough K; McVernon J; Brown LE; Jackson DC
    Mol Pharm; 2012 Sep; 9(9):2710-8. PubMed ID: 22823162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.